Hamid Trimech is a talented process engineer passionate about vaccine manufacturing. For over 8 years in the vaccine industry, Hamid has led numerous projects involving the design, construction, and qualification of drug substance manufacturing facilities. Throughout his activities, he has supported technology transfers, process validations, and commercial manufacturing of a wide range of vaccine technologies, including whole cell, acellular pertussis, egg-based flu, rabies, diphtheria, tetanus, pneumococcal conjugate, recombinant protein COVID-19, and mRNA-based COVID-19 vaccines. Since joining ARCALIS in September 2022, Hamid has taken on the role of Project Leader. In this capacity, he has successfully led the construction of ARCALIS' drug substance facility and the technology transfer of sa-mRNA and LNP manufacturing processes. Since 2025, Hamid has taken on business development in addition to his existing responsibilities. He is now leading the team as the Head of the Business Development Division.